The effect of iron supplementation in pregnant women with high hemoglobin

The effect of iron supplementation on iron status markers in pregnant women with High Hemoglobin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013020612383N1

Enrollment

Registered

2014-06-27

Start date

2014-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high hemoglobin. Nutritional and metabolic disorders in diseases classified elsewhere

Interventions

Intervention 1: Iron suplementation in pregnant women with high hemoglobin. Intervention 2: use of plasebo of iron in preganant women with high hemoglobin.

Prevention

Placebo

Iron suplementation in pregnant women with high hemoglobin

use of plasebo of iron in preganant women with high hemoglobin

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were being between 18 and 35 years of maternal age; having a body mass index between 19.8 and 26kg/m2, Hb>13/2g/dl,fr>15µg/l and having a singleton pregnancy.Exclusion criteria were smoking; having a disease related to polycythemia; such as asthma or chronic renal diseases, malignancy and preterm delivery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Iron status markers. Timepoint: before intervention, 20 weeks later. Method of measurement: evaluation of hb and ferritin levels.	—

Secondary

Measure	Time frame
Anemia. Timepoint: the end of pregnancy. Method of measurement: chek of Hb & ferritin.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlizadeh Leila

Ardabil branch, Islamic Azad University

Alizadehl.ms@gmail.com+98 45 1771 5910

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026